We describe a novel plasma membrane cystine transporter, CgCYN1, from Candida glabrata, the first such transporter to be described from yeast and fungi. C. glabrata met15⌬ strains, organic sulfur auxotrophs, were observed to utilize cystine as a sulfur source, and this phenotype was exploited in the discovery of CgCYN1. Heterologous expression of CgCYN1 in Saccharomyces cerevisiae met15⌬ strains conferred the ability of S. cerevisiae strains to grow on cystine. Deletion of the CgCYN1 ORF (CAGL0M00154g) in C. glabrata met15⌬ strains caused abrogation of growth on cystine with growth being restored when CgCYN1 was reintroduced. The CgCYN1 protein belongs to the amino acid permease family of transporters, with no similarity to known plasma membrane cystine transporters of bacteria and humans, or lysosomal cystine transporters of humans/ yeast. Kinetic studies revealed a K m of 18 ؎ 5 M for cystine. Cystine uptake was inhibited by cystine, but not by other amino acids, including cysteine. The structurally similar cystathionine, lanthionine, and selenocystine alone inhibited transport, confirming that the transporter was specific for cystine. CgCYN1 localized to the plasma membrane and transport was energy-dependent. Functional orthologues could be demonstrated from other pathogenic yeast like Candida albicans and Histoplasma capsulatum, but were absent in Schizosaccharomyces pombe and S. cerevisiae.
the ability to survive within the human host, and any new proteins acquired by this yeast can be considered likely to play a very significant role in pathogenesis within the human host.
Like all living forms, yeast pathogens require essential nutrients for their survival. Sulfur is one of the essential requirements being a part of two important amino acids cysteine and methionine, as well as several other essential sulfur-containing compounds including glutathione and coenzyme A. Yeast pathogens must fulfill this requirement of sulfur by retrieving them from their human host. C. glabrata, like many yeast, can use both inorganic and organic forms of sulfur and have been demonstrated to have both forward and reverse transsulfuration pathways for the conversion of cysteine to methionine and also from methionine to cysteine (3) . Although the sulfur assimilatory pathways were found to be very similar to that of S. cerevisiae, one important difference was found in the utilization of glutathione where C. glabrata was found to lack the ability to transport glutathione because of the absence of a high affinity glutathione transporter thus relying solely on the endogenous biosynthesis of glutathione for its survival (3) . Interestingly, when one looks at the presence of sulfur compounds in the human blood plasma, glutathione is found in negligible amounts, whereas the most predominant organic sulfur form found in blood plasma is cystine (the oxidized form of cysteine) (4) .
The preponderance of cystine in human plasma suggests that sulfur requirements in pathogenic yeast might involve their utilization of cystine. Interestingly, in a study done four decades ago, in another important yeast pathogen, Histoplasma capsulatum, cystine uptake was demonstrated in the yeast phase of this dimorphic yeast. However, the gene responsible for the phenotype was never discovered (5), despite plasma membrane cystine transporters having being described in both humans (6 -8) and bacteria (9 -12) .
C. glabrata is a pathogen whose molecular genetics have now been reasonably well developed. Further, its haploid nature makes it much easier to manipute than C. albicans. We therefore investigated the ability of C. glabrata to utilize cystine and exploited the met15⌬ strains that are organic sulfur auxotrophs. We describe here the identification and characterization of a high affinity, plasma membrane cystine-specific transporter CgCYN1 that confers the ability of this yeast to utilize cystine. The transporter was demonstrated to have functional orthologues in the pathogenic yeast C. albicans and H. capsla-tum, but was absent in the nonpathogenic yeast S. cerevisiae and Schizosaccharomyces pombe.
MATERIALS AND METHODS
All chemicals and reagents were of analytical reagent grade and were procured from different commercial sources. Medium components were purchased from BD (Difco). Oligonucleotide primers were synthesized from Sigma-Genosys (see supplemental 3 Cys-Cys dipeptide was custom synthesized from an in-house peptide synthesizer.
Strains, Media, and Growth Conditions-The Escherichia coli strain DH5␣ was used as a cloning host. S. cerevisiae, C. glabrata, C. albicans, S. pombe strains used in the study are described in Table 1 . S. cerevisiae, C. albicans, and C. glabrata strains were regularly maintained on yeast extract, peptone, and dextrose medium (YPD) whereas S. pombe was maintained on YES medium. Synthetic defined minimal medium contained yeast nitrogen base, ammonium sulfate, dextrose supplemented with methionine, cysteine, cystine, cystathionine, histidine, leucine, lysine (as per requirement), and uracil at 50 mg/liter. Yeast transformations were carried out using the modified lithium acetate method as described for C. glabrata (13) an for C. albicans using SAT1 flipper as disruption cassette (14) .
Cloning and Tagging of CYN1 Gene from C. glabrata-CYN1 (CAGL0M00154g) gene was PCR-amplified from the genomic DNA of C. glabrata using primers CgCYN1F and CgCYN1R to obtain a 1.6-kb fragment, which was then cloned in C. glabrata (pGRB2.2)-and S. cerevisiae (p416TEF)-specific vectors in BamHI and XhoI sites to obtain plasmid pGRB2.2-CgCYN1 and p416TEF-ScCYN1, respectively.
For hemagglutinin (HA) tagging CYN1 gene pGRB2.2-Cg-CYN1 was taken as the template for PCR and HA tag was introduced just before the end codon of CgCYN1 using the PCR where the reverse primer had the HA tag (CgCYN1HAR) to yield plasmid pGRB2.2-CgCYN1HA.
Cloning of CYN1 Gene from C. albicans, H. capsulatum, and S. pombe-A putative orthologue of CgCYN1 in C. albicans (ORF Ca019.9873) was PCR-amplified from the genomic DNA of C. albicans with primers CaCYN1F and CaCYN1R and cloned in the EcoRI and XhoI sites of p416TEF to obtain plasmid p416TEF-CaCYN1.
A putative orthologue of CgCYN1 in H. capsulatum, HCAG_06385, had two introns. Its cDNA was custom synthesized by Genescript which was then cloned in the BamHI and XhoI sites of p416TEF to obtain p416TEF-HcCYN1.
S. pombe ORF SPCPB1C11.02 was PCR-amplified from the genomic DNA of S. pombe using primers SpC11.02F and SpC11.02R and cloned in to the XbaI and SmaI sites of p416TEF to obtain plasmid p416TEF-Sp11.02.
Construction of C. glabrata Cgcyn1⌬-Plasmid p416TEF-Cg-CYN1 prepared from a dam Ϫ dcm Ϫ E. coli strain was digested with BclI and a HisG-Ura3-HisG cassette inserted in this site. This cassette was released from plasmid PHUKH2M (derived from pHUKH2 (15) and lacks the BamHI and XhoI sites), and the resulting ligation yielded p416TEF-CgCYN1M:HisG-Ura3-HisG.
The disruption cassette was released from plasmid p416TEF-CgCYN1M:HisG-Ura3-HisG by BamHI-XhoI digestion and transformed into C. glabrata met15⌬ura3⌬ (ABG 2370). Transformants were selected on minimal medium lacking uracil with methionine as the sulfur source. The disruption was confirmed by diagnostic PCR. To remove the URA3 marker from the disruptant 5-fluoroorotic acid selection was performed using 0.1% 5-fluoroorotic acid and selecting the transformants on minimal medium with uracil (1.2 mg/100 ml) and methionine.
Construction of C. albicans Cacyn1⌬/Cacyn1⌬-To delete both the alleles of CaCYN1 (ORF Ca019.9873) in C. albicans we employed the nourseothricin disruption cassette and the SAT1 flipper strategy (using primers CaCYN1DF1, CaCYN1DF2, CaCYN1DR1, and CaCYN1DR2). The absence of a third allele for CaCYN1 was confirmed by the absence of a PCR product with primers CaCYN1 ϩ 450F (anneals in the region which is removed in the two disrupted alleles) and CaCYN1R.
Growth Assays by Dilution Spotting-For dilution spotting assays, the different transformants were grown overnight in minimal medium with supplements but without uracil and reinoculated in fresh medium to an A 600 of 0.1 and grown for 6 h. The exponential phase cells were harvested washed with water and resuspend in water to an A 600 of 0.2. These were serially diluted to 1:10, 1:100, and 1:1000. Of these cell suspensions, 10 l of the each dilution was spotted on the desired plates. Plates were incubated for 2 days, and photographs were taken.
Cellular Localization of HA-tagged CgCYN1-For the localization studies Cgmet15⌬CYN1⌬ was transformed with the 3 The abbreviations used are: ARC, American Radiolabeled Chemicals; PGK, phosphoglycerate kinase; TEF, translation elongation factor. HA-tagged CgCYN1, and the transformants were used for the indirect immunofluorescence as described earlier (16) . Construction of Phylogenetic Tree-The protein sequence of C. glabrata CYN1 was used as a query sequence in BLAST to retrieve a current list of homologues of CgCYN1 in the fungal taxa. The protein sequences were then retrieved and aligned using ClustalW (17) . The evolutionary history was inferred using the Neighbor-Joining method (18) using MEGA4 (19) .
Radioactive Cystine Transport Assay-S. cerevisae met15⌬yct1⌬ strain (ABC 1904) was transformed with C. glabrata CYN1 gene under the TEF promoter in plasmid p416TEF and with the vector control p416TEF. The transformants were grown in minimal medium containing methionine and other supplements overnight. Overnight cultures were reinoculated in the same fresh medium at an A 600 of 0.1 and were allowed to grow until the cells reached the exponential phase, after which they were harvested, washed with ice-cold MES buffer, and then resuspended in the same MES buffer containing 2% glucose. After a 5-min preincubation of cells at 30°C the transport experiment was initiated by adding radioactive cystine supplied by ARC, having a specific activity of 850 mCi/ mmol) in MES buffer at a final concentration of 20 M, and transport was monitored for 11 min. At selected time points (1, 3, 5, 7, 9, and 11 min) cells were harvested on a glass fiber prefilter (Advanced Microdevices, Ambala, India) and washed with excess cold water by vacuum filtration. The cells were then immersed in 3 ml of scintillation fluid (Sigma Flour Universal LSC mixture), and radioactivity was measured on a liquid scintillation counter (Wallac Microbeta, 1450 LSC and luminescence counter, PerkinElmer Life Sciences), and the results were expressed as nmol of cystine/mg of protein/min. Total protein was measured as previously described (16) .
For saturation kinetics, the initial rate of cystine uptake was measured at different concentrations ranging from 2.5 to 160 M (160, 80, 40, 20, 10, 5, and 2.5 M), with specific activity being kept constant at each concentration. The initial rate of cystine uptake was determined by measuring the radioactive cystine accumulated in the cells up to 2 min.
For inhibition studies done with different sulfur compounds, amino acids, and structural analogues of cystine, the inhibitors were added at 20-fold excess along with the assay medium, and initial rates of cystine uptake were measured. For the studies done with the metabolic inhibitors cells were preincubated with the metabolic inhibitors for 15 min at 30°C before measuring the initial rate of cystine uptake.
RESULTS

Isolation of CAGL0M00154g as an ORF That Allows Utilization of Cystine as a Sulfur
Source in C. glabrata-C. glabrata met15⌬ strains, like S. cerevisiae met15⌬ strains, are organic sulfur auxotrophs and have been previously shown to utilize both cysteine and methionine as a sulfur source suggesting the existence of both forward and reverse transsulfuration pathways in C. glabrata (3) . We used this C. glabrata met15⌬ strain to test for the growth on cystine. Interestingly, we observed that C. glabrata met15⌬ could utilize cystine as a sulfur source whereas S. cerevisiae met15⌬ failed to do so (Fig. 1A) .
To identify the gene(s) in C. glabrata that were conferring the ability to grow on cystine, we complemented the S. cerevisiae met15⌬ strain with a genomic library of C. glabrata made in a S. cerevisiae-specific vector YEp24. Transformants were selected on minimal medium with cystine as the sole organic sulfur source. A total of 20 transformants were obtained. These transformants were replica-patched on ammonium sulfate, and 16 transformants were found to grow on ammonium sulfate. These were not followed further because they were likely to contain the CgMET15 gene complementing in the Scmet15⌬ strain. Plasmids were isolated from those transformants that could grow only on cystine and not on ammonium sulfate and reconfirmed for their phenotype following retransformation in S. cerevisiae met15⌬ strain. Sequencing of the inserts using YEp24-specific primers (YEp24F and YEp24R) in these four plasmids revealed a common ORF, CAGL0M00154g. The ORF CAGL0M00154g was amplified from the genome of C. glabrata and cloned into the yeast expression vector p416TEF. Heterologous expression of CAGL0M00154g conferred the capability of S. cerevisiae met15⌬ strain to grow on cystine (supplemental Fig. 1 ).
To further ascertain that ORF CAGL0M00154g was indeed the ORF of C. glabrata that was conferring the ability of C. glabrata to grow on cystine, we deleted the ORF in a C. glabrata met15⌬ strain. A complete growth defect was seen on cystine which could be restored by reintroducing ORF CAGL0M00154g expressed from the constitutive PGK promoter in C. glabrata-specific vector pGRB2.2 (Fig. 1B) .
ORF CAGL0M00154g (CgCYN1) Is a High Affinity Cystine Transporter-The sequence analysis of ORF CAGL0M00154g revealed that it encoded a protein of 550 amino acids having 12 predicted transmembrane domains (see Fig. 8A ) and belongs to the amino acid permease family of proteins. Based on the phenotypes, it appeared that it was likely to be a cystine transporter. Uptake experiments were performed using 35 S-labeled cystine to examine this possibility in C. glabrata. However, our initial experiments were complicated by the observation of the presence of radioactive cysteine that was apparent in the radioactive cystine supplied by ARC. This was confirmed by a variety of transport experiments (data not shown) exploiting the S. cerevisiae yct1⌬met15⌬ strain background. YCT1 is a high affinity cysteine-specific transporter that does not transport cystine as described previously (17) . Briefly, TEF-YCT1 transformed into S. cerevisiae yct1⌬met15⌬ also revealed radioactive uptake using the ARC-supplied radioactive cystine (blocked by cold cysteine, but not cystine). In contrast, TEF-CgCYN1-transformed strains also showed uptake (but blocked by cold cystine, not cysteine). Furthermore, TEF-YCT1 (but not TEF-CgCYN1) transformants could take up [
35 S]cysteine (from Bhabha Atomic Research Centre). The presence of specific cysteine (and now cystine) transporters has allowed us to develop this is as a simple bioassay for the presence of cysteine and cystine in these radioactive samples. 4 Because of the presence of contaminating radioactive cysteine, the kinetic parameters for the C. glabrata ORF was determined in the S. cerevisiae yct1⌬ met15⌬ strains thus eliminating any interference from the contaminating cysteine in the radioactive cystine supplied by ARC. We thus could get rid of the background given by the radioactive cysteine. Thus, when yct1⌬met15⌬ strain was transformed with TEF-CgCYN1 a clear difference could be seen between the experimental transformant (yct1⌬met15⌬/TEF-CgCYN1) as opposed to the control transformant (yct1⌬met15⌬/TEF) ( Fig. 2A) .
To determine the K m and the V max values for CgCYN1, S. cerevisiae yct1⌬met15⌬ strain was again transformed with the cystine transporter CgCYN1 under the TEF promoter in S. cerevisiae yct1⌬met15⌬ strain along with the vector control p416TEF. Substrate concentrations ranging from 2.5 to 160 M were used for determining the kinetic parameters. The K m value of 18 Ϯ 5 M and a V max of 14 Ϯ 4 nmol of cystine/mg of protein/min were found for the newly found cystine transporter. A K m value of 18 Ϯ 5 M suggests that the newly found cystine transporter is a high affinity cystine transporter (Fig.  2B) . We have accordingly named ORF CAGL0M00154g as CYN1.
CgCYN1 Is a Cystine-specific Transporter-To examine the substrate specificity of CgCYN1, the rate of uptake of cystine was measured in S. cerevisiae yct1⌬met15⌬ strain transformed with CgCYN1 in the presence of different amino acids, cystine analogues, and various sulfur compounds. These inhibitors were added at Ͼ20-fold excess over the labeled substrate. The cells were harvested at 1-and 2-min intervals, and the results were normalized to the rate of uptake measured in the absence of any inhibitor.
Among the various amino acids like glycine, glutamic acid, cysteine, homocysteine, methionine, leucine, proline, valine, phenylalanine, serine, glutamine, and lysine, none could inhibit the transport for cystine thus showing the specificity of CYN1 for cystine (Fig. 3A) . Among the sulfur-containing compounds such as cysteamine hydrochloride, cystic acid, glutathione, cystathionine, and Cys-Cys dipeptide, only cystine and cystathionine could inhibit the transport (Fig. 3B) . When one looks at the structure of these two compounds the structures are very similar and differ only in that the cystathionine has a single sulfur atom instead of two in cystine (Fig. 3E) . Seeing the significant transport inhibition by cystathionine, the growth of Cgmet15⌬cyn1⌬ was checked on cystathionine, and we observed that Cgmet15⌬ strain could utilize cystathionine as a sole source of sulfur in a CYN1-dependent manner (Fig. 4) .
Among the structural homologues to cystine, various compounds like 2,6-diamino pimelic acid, methionine sulfoxide, cystine dimethyl ester dihydrochloride, lanthionine, and sel-enocystine were taken for the competitive experiments at a 20-fold molar excess over the substrate, and it was found that only lanthionine and selenocystine could inhibit the transport by CgCYN1 (Fig. 3C) . Structurally, selenocystine is like cystine where the sulfur atoms of cystine have been replaced with selenium in selenocystine, and lanthionine is more similar to cystathionine and differs in that it lacks one carbon atom compared with cystathionine (Fig. 3E) .
To determine whether the uptake of cystine by CgCYN1 is energy-dependent, metabolic inhibitors like sodium azide and carbonyl cyanide p-chlorophenylhydrazone were used at 50 and 100 M concentrations. A 15-min preincubation of these inhibitors with the transformants expressing the cystine transporter (Scyct1⌬met15⌬/TEF-CgCYN1) resulted in a considerable loss in the cystine uptake thus suggesting that cystine transport by CgCYN1 is energy mediated (Fig. 3D) .
CgCYN1 Localizes to the Plasma Membrane-The ability of CgCYN1 to take up cystine with high affinity from whole cells suggested that it was a plasma membrane transporter. To confirm this, CgCYN1 was tagged with a nine-amino acid HA tag at the C terminus and expressed from the constitutive PGK promoter in the C. glabrata vector pGRB2.2. The tagged protein was functional as seen by complementation in the Cgmet15⌬cyn1⌬ strain (supplemental Fig. 2 ). Indirect immunofluorescence was done using confocal microscopy as described under "Materials and Methods." We observed a signal only on the plasma membrane (Fig. 5) . No intracellular signal was seen in all cells. This confirmed that CgCYN1 is exclusively localized to the plasma membrane.
H. capsulatum and C. albicans Orthologues of CgCYN1 Also Function as Cystine Transporters-We examined for the presence of CgCYN1 orthologues in the pathogenic yeast, H. capsulatum and C. albicans. In C. albicans ORF Ca019.9873 (similarity of 74% and identity of 57%) appeared as the putative orthologue. This ORF was cloned, and transformed in an S. cerevisiae met15⌬ background. We observed that Ca019.9873 (CaCYN1) could complement in S. cerevisiae very effectively for growth on cystine (Fig. 6A) . To further validate the role of C. albicans ORF Ca019.9873 in cystine transport we deleted this ORF in a met15⌬ background of C. albicans and (n ϭ 2) . B, inhibition of cystine uptake by different sulfur compounds. The rate of cystine uptake was measured in S. cerevisiae met15⌬yct1⌬ strain transformed with the cystine transporter CYN1 in the presence of different inhibitors added at 20-fold excess over the labeled substrate (15 M). The cells were harvested at 1-and 2-min intervals. The results were normalized to the rate of uptake measured in the absence of any inhibitor. Data are shown as mean Ϯ S.D. (n ϭ 2). Inhibitors L-cystine, lanthionine, and DL-selenocystine were dissolved in a buffer of pH 1 (50 mM KCl-HCl, pH 1), hence the buffer was analyzed for its effect on cystine uptake. C, inhibition of cystine uptake by different cystine analog. The rate of cystine uptake was measured in S. cerevisiae met15⌬yct1⌬ strain transformed with the cystine transporter CYN1 in the presence of different inhibitors added at 20-fold excess over the labeled substrate (15 M). The cells were harvested at 1-and 2-min intervals. The results were normalized to the rate of uptake measured in the absence of any inhibitor. Data are shown as mean Ϯ S.D. (n ϭ 2). D, inhibition of cystine uptake by metabolic inhibitors. The rate of cystine uptake was measured in S. cerevisiae met15⌬yct1⌬ strain transformed with the cystine transporter CYN1 which was preincubated with the metabolic inhibitors as described under "Materials and Methods." Data are shown as mean Ϯ S.D. (n ϭ 2). Cells were preincubated with the indicated concentrations of metabolic inhibitors for 15 min prior to the addition of the uptake medium. Carbonyl cyanide p-chlorophenylhydrazone (CCCP) was dissolved in dimethyl sulfoxide (DMSO), and thus it was analyzed for its effect on cystine uptake. E, structure of different inhibitors inhibiting the cystine transport by CgCYN1. Cgmet15⌬cyn1⌬ strain complemented with HA-tagged CgCYN1 under the constitutive PGK promoter was labeled by indirect immunofluorescence using mouse anti-HA primary antibody (1:250) and goat anti-mouse IgG HRPconjugated secondary antibody followed by visualization using the confocal microscope as described under "Materials and Methods."
found that the deletion caused abrogation of growth on cystine. The residual growth seen on cystine plates is the result of only partial organic sulfur auxotrophy seen in C. albicans met15⌬ strain (20) and not a consequence of growth on cystine. This clearly indicated that ORF Ca019.9873 encodes for a functional cystine transporter in C. albicans (Fig. 6C) .
H. capsulatum is a dimorphic fungus where cystine uptake has been seen in the yeast phase (4) . In H. capsulatum ORF HCAG_06385 appeared to be the orthologue of the C. glabrata CYN1 protein (identity of 56% and similarity of 73%). ORF HCAG_06385 contained two introns, so we custom synthesized the cDNA and expressed it downstream of the TEF promoter in p416TEF followed by transforming it in S. cerevisiae met15⌬ strain. We observed that the ORF complemented for growth on cystine in S. cerevisiae, indicating that ORF HCAG_06385 of H. capsulatum is also a cystine transporter (Fig. 6B) . Thus, it can be concluded that CgCYN1 has functional homologues in C. albicans and H. capsulatum (multiple sequence alignment is shown in Fig. 8B) .
The S. cerevisiae Homologue of CgCYN1 Is a Lysine Permease (LYP1), and the S. pombe Orthologue for CgCYN1 (SPCPB1C11.02) Has No Role in Cystine Transport-S. cerevisiae lacks the ability to grow on cystine as described earlier and was thus likely to lack an orthologue of CgCYN1. The closest homologue of CgCYN1 in S. cerevisiae is LYP1 which is a lysine transporter (identity 37%). LYP1 is also a member of the AAP family whose orthologue exists in C. glabrata (CAGL0J08162g).
When seeking the orthologue of CYN1 in the S. pombe genome, ORF SPCPB1C11.02 was picked up (having a identity of 41% and similarity of 62%). This also appeared to be the orthologue from reverse BLAST analysis. S. pombe also has a distinct lysine permease distinct from this ORF. To examine whether ORF SPCPB1C11.02 functioned as a cystine transporter we cloned and expressed this in S. cerevisiae met15⌬ strain to see whether it could enable S. cerevisiae to utilize cystine. However, even when SPCPB1C11.02 was overexpressed under the TEF promoter and transformed in S. cerevisiae met15⌬ strain, it could not confer growth on cystine (supplemental Fig. 3A) . To eliminate the possibility that it might be a problem of heterologous expression, we examined the cys1a⌬ strain of S. pombe which is a cysteine auxotroph (21) for growth on cystine. We found that it could not grow on cystine even at high concentrations of cystine (600 M), further confirming that S. pombe lacked a cystine transporter (supplemental Fig.  3B ).
CgCYN1 Represents a Novel Family of Cystine TransportersThe presence of cystine transporters in three pathogenic yeast species, and its absence among S. cerevisiae and S. pombe, prompted us to do a phylogenetic analysis of these transporters in different yeast and fungi. The lysine permease, LYP1 of S. cerevisiae, was the closest homologue of CgCYN1 in S. cerevisiae (37% identity, 57% similarity), and C. glabrata also contained a separate LYP1 orthologue. We therefore extracted the close homologues of CgCYN1 in different yeast and fungi, while also extracting the lysine permease homologues of these different species. When we look at the phylogenetic tree there seems to be clear distinction between the lysine transporters and the cystine transporters clusters (Fig. 7) . Furthermore, the CgCYN1 orthologues appeared to be present among many Aspergillus species. These organism, like C. glabrata, also contained orthologues of the S. cerevisiae lysine permease, LYP1. S. pombe contained a LYP1 orthologue, but also contained an ORF SPCPB1C11.02 lying somewhere between these two clusters. However, this ORF did not appear to function as a cystine transporter as described above (Fig. 8) .
DISCUSSION
The work presented here describes a novel plasma membrane cystine transporter of yeast. The transporter belongs to a distinctly different family from that previously reported for cystine transporters of humans and bacteria. Humans have the heterodimeric Na ϩ -independent cystine/glutamate transporter (system x c Ϫ ) that mediates the uptake the cystine against the exchange of glutamate (22) , and a second b 0ϩ transporter that takes up cystine (or dibasic amino acids) against the efflux of neutral amino acids (23) . The lysosomal cystine transporter of mammals, CTNS, which has functional homologues in the yeast vacuoles (ERS1) (24) and is involved in H ϩ -driven efflux of cystine from these organelles, also belongs to a separate family of transporters (LCT). Bacteria have both high and low affinity transporters of cystine, and most of them belong to the ABC uptake system. However, in Bacillus subtilis, out of three transporters transporting cystine (TcyP, TcyJKLMN, and TcyABC) TcyP belongs to the dicarboxylate amino acid cation symporter family.
The existence of a pathway for cystine utilization in pathogenic yeast was not unexpected, considering that cystine is the most abundant sulfur compound in blood plasma. Cystine transport has been described in H. capsulatum 4 decades ago (4), but the gene was never identified. Cystine utilization has also been documented in dermatophytes like Microsporum gypseum (25) which secrete sulfite that reduces the cystine in keratin (present in abundance in their ecological niche) to cysteine and S-sulfocysteine, which are then subsequently taken up following proteolysis (26, 27) . Which of these or other pathways might operate in C. glabrata was not clear. The findings described here have revealed that a novel transporter was mediating the utilization in not only C. glabrata but also in C. albi-cans and H. capsulatum. The discovery thus also takes to a satisfying conclusion the observations made with H. capsulatum 40 years ago.
There are two possible reasons that might have delayed the discovery of the identity of this transporter. The first is that much of the work on sulfur and amino acid transporters has focused on S. cerevisiae and S. pombe, and the transporter is lacking in these yeast species. A second reason might be due to the observation made in this work that the radioactive cystine had substantial levels of radioactive cysteine. It is possible that samples of radioactive cystine may sometimes carry this contamination with cysteine. However, as yeast species also carry transporters of cysteine, the identification of a cystine transporter can be masked or complicated in such a situation. In the present study we were greatly assisted in our studies by our use of the S. cerevisiae strain defective in high affinity cysteine uptake (yct1⌬). Using this strain has eliminated background cysteine uptake and has been a powerful aid to uncovering this cystine transporter from C. glabrata.
Cystathionine, an intermediate in cysteine biosynthesis in yeast, was found to be a potent inhibitor of transport along with cystine, and when one looks at the structure of these two compounds the structures are very similar except that the cystathionine has a single sulfur atom instead of two in cystine (Fig. 3E) . Cystathionine is also present at low levels in blood plasma (3) . Not surprisingly, we observed that cystathionine could also be used efficiently as a sulfur source in this yeast. The only other two inhibitors were known cystine analogues, lanthionine and selenocystine, which indicates the high specificity of the transporter for cystine. No other amino acid, including cysteine or even lysine, could inhibit cysteine transport through this transporter.
The K m of CgCYN1 for cystine was found to be 18 M, a value very close to the value of 30 M described for H. capsulatum many years ago (5) and close to the reported concentrations of cystine (50 M) in the blood plasma (4). Although bacterial cystine transporters have been reported of still higher affinity, the affinity of CgCYN1 is also reasonably high considering the fact that it is in the micromolar range and thus it would be adequate for this transporter to be effective in vivo.
Because C. glabrata lacks a glutathione transporter and relies solely on the endogenous production of glutathione for its survival (3) the presence of a cystine transporter would be important for the cell not only for meeting the cysteine requirements, but also to meet the glutathione requirements, because cysteine is rate-limiting for glutathione synthesis in vivo. Increased glutathione requirements become very crucial under the conditions of stress as survival in the host is in itself a stress for the pathogen.
CYN1 orthologues were absent in S. cerevisiae, and despite an apparent orthologue in S. pombe, there was no cystine transporter in the fission yeast as well. In contrast, cystine transporters seem to have been acquired by a large number of pathogenic yeast, with orthologues also appearing to be present in many aspergilli. Whether the presence of this gene actually leads to a defect in virulence in these organisms, however, remains to be established. Nevertheless, the acquisition of a new gene (CYN1) in an otherwise slimmer C. glabrata genome (C. glabrata has 398 membrane proteins whereas S. cerevisiae has 502 membrane proteins) (28) and the prevalence of this transporter among pathogenic yeast and fungi seem to suggest that it may play an important role in their in vivo survival.
